Clinical Trial Update: FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of FID-007 followed by standard of care surgery for head and neck squamous cell carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• FID-007

Snippet

Sponsor: University of Southern California | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: TERMINATED